Log In Sign up
The largest database of trusted experimental protocols

Human complement c5 elisa kit

Manufactured by Abcam
Visit Supplier
Sourced in United Kingdom

The Human Complement C5 ELISA Kit is a quantitative sandwich enzyme-linked immunosorbent assay (ELISA) designed for the measurement of human complement C5 levels in serum, plasma, and other biological fluids.

Automatically generated - may contain errors

Lab products found in correlation

Human complement c3 elisa kit, by Abcam (2 mentions)

Spelling variants of this product

ELISAs (10 citations) Complement C5 Human ELISA Kit ab125963 (2 citations)

3 protocols using human complement c5 elisa kit

1

Quantifying Plasma Complement C5 and C3

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma levels of C5 (including the sum of C5 and C5a) and C3 (including the sum of C3, C3a and C3b) were detected using Human Complement C5 ELISA Kit and Human Complement C3 ELISA Kit (Abcam) according to the manufacturer’s instruction.
Zhang Y., Han K., Du C., Li R., Liu J., Zeng H., Zhu L, & Li A. (2021). Carboxypeptidase B blocks ex vivo activation of the anaphylatoxin-neutrophil extracellular trap axis in neutrophils from COVID-19 patients. Critical Care, 25, 51.
+ Open protocol
+ Expand
2

Quantifying Plasma Complement Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma levels of C5 (including C5 and C5a) and C3 (including C3, C3a and C3b) were detected using Human Complement C5 ELISA Kit and Human Complement C3 ELISA Kit (Abcam) according to the manufacturer's instruction.
Zhang Y., Han K., Du C., Li R., Liu J., Zeng H., Zhu L., & Li J. (2020). Carboxypeptidase B Inhibits Over-activation of Anaphylatoxin-neutrophil Extracellular Trap Axis in COVID-19 Patients.
+ Open protocol
+ Expand
3

C5 Levels in aHUS Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
C5 concentrations were measured in available sera or EDTA plasma, that were collected from 10 aHUS patients in acute phase, before the start of eculizumab therapy and from nine healthy volunteers. The C5 levels were measured using Human Complement C5 ELISA Kit (Abcam, Cambridge, UK), according to manufacturer's instructions.
Volokhina E., Wijnsma K., van der Molen R., Roeleveld N., van der Velden T., Goertz J., Sweep F., Brüggemann R.J., Wetzels J., van de Kar N, & van den Heuvel L. (2017). Eculizumab Dosing Regimen in Atypical HUS: Possibilities for Individualized Treatment. Clinical pharmacology and therapeutics, 102(4).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!